{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T18:07:49Z","timestamp":1793729269792,"version":"4.6.1"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T00:00:00Z","timestamp":1701820800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T00:00:00Z","timestamp":1701820800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Highly prevalent hepatitis B and hepatitis C virus (HBV and HCV) infections have been reported among individuals with diabetes. Given the frequently asymptomatic nature of hepatitis and the challenges associated with screening in some vulnerable populations such as diabetes patients, we conducted an investigation into the performance of various machine learning models for the identification of hepatitis in diabetic patients while also evaluating the significance of features. Analyzing NHANES data from 2013 to 2018, machine learning models were evaluated; random forest (RF), support vector machine (SVM), eXtreme Gradient Boosting (XGBoost), and least absolute shrinkage and selection operator (LASSO) along with stacked ensemble model. We performed hyperparameter tuning to improve the performance of the model, and selected important predictors using the best performance model. LASSO showed the highest predictive performance (AUC-ROC\u2009=\u20090.810) rather than other models. Illicit drug use, poverty, and race were highly ranked as predictive factors for developing hepatitis in diabetes patients. Our study demonstrated that a machine-learning-based model performed optimally in the detection of hepatitis among diabetes patients, achieving high performance. Furthermore, models and predictors evaluated from the current study, we expect, could be supportive information for developing screening or treatment methods for hepatitis care in diabetes patients.<\/jats:p>","DOI":"10.1038\/s41598-023-49046-9","type":"journal-article","created":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T13:26:48Z","timestamp":1701869208000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Machine learning for predicting hepatitis B or C virus infection in diabetic patients"],"prefix":"10.1038","volume":"13","author":[{"given":"Sun\u2013Hwa","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"So\u2013Hyeon","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heeyoung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,6]]},"reference":[{"key":"49046_CR1","doi-asserted-by":"publisher","first-page":"3719","DOI":"10.3390\/nu12123719","volume":"12","author":"DM Tanase","year":"2020","unstructured":"Tanase, D. M. et al. Role of gut microbiota on onset and progression of microvascular complications of type 2 diabetes (T2DM). Nutrients 12, 3719. https:\/\/doi.org\/10.3390\/nu12123719 (2020).","journal-title":"Nutrients"},{"key":"49046_CR2","unstructured":"Control, C. F. D. National diabetes statistics report: Estimates of diabetes and its burden in the United States, 2014. Atlanta, GA: US Department of Health and Human Services (2014)."},{"key":"49046_CR3","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.2337\/dc20-S002","volume":"43","author":"Classifcation and Diagnosis of Diabetes","year":"2020","unstructured":"Classifcation and Diagnosis of Diabetes. Standards of medical care in diabetes-2020. Diabetes Care 43, S14-s31 (2020).","journal-title":"Diabetes Care"},{"key":"49046_CR4","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.2522\/ptj.20080020","volume":"88","author":"AD Deshpande","year":"2008","unstructured":"Deshpande, A. D., Harris-Hayes, M. & Schootman, M. Epidemiology of diabetes and diabetes-related complications. Phys. Ther. 88, 1254\u20131264. https:\/\/doi.org\/10.2522\/ptj.20080020 (2008).","journal-title":"Phys. Ther."},{"key":"49046_CR5","first-page":"1709","volume":"60","author":"CFD Control","year":"2011","unstructured":"Control, C. F. D. Use of hepatitis B vaccination for adults with diabetes mellitus: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb. Mortal. Wkly. Rep. 60, 1709\u20131711 (2011).","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"49046_CR6","first-page":"453","volume":"64","author":"JE Zibbell","year":"2015","unstructured":"Zibbell, J. E. et al. Increases in hepatitis C virus infection related to injection drug use among persons aged \u226430 years - Kentucky, Tennessee, Virginia, and West Virginia, 2006\u20132012. MMWR Morb. Mortal. Wkly. Rep. 64, 453\u2013458 (2015).","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"49046_CR7","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.amepre.2021.04.029","volume":"61","author":"PJ Lu","year":"2021","unstructured":"Lu, P. J., Hung, M. C., Srivastav, A., Williams, W. W. & Harris, A. M. Hepatitis B vaccination among adults with diabetes mellitus, U.S., 2018. Am. J. Prev. Med. 61, 652\u2013664. https:\/\/doi.org\/10.1016\/j.amepre.2021.04.029 (2021).","journal-title":"Am. J. Prev. Med."},{"key":"49046_CR8","doi-asserted-by":"publisher","first-page":"105","DOI":"10.5114\/pg.2016.64748","volume":"12","author":"K Gisi","year":"2017","unstructured":"Gisi, K. et al. Hepatitis B and C seroprevalence in patients with diabetes mellitus and its relationship with microvascular complications. Prz. Gastroenterol. 12, 105\u2013110. https:\/\/doi.org\/10.5114\/pg.2016.64748 (2017).","journal-title":"Prz. Gastroenterol."},{"key":"49046_CR9","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/s1590-8658(00)80850-6","volume":"32","author":"C Puoti","year":"2000","unstructured":"Puoti, C., Castellacci, R. & Montagnese, F. Hepatitis C virus carriers with persistently normal aminotransferase levels: Healthy people or true patients?. Dig. Liver Dis. 32, 634\u2013643. https:\/\/doi.org\/10.1016\/s1590-8658(00)80850-6 (2000).","journal-title":"Dig. Liver Dis."},{"key":"49046_CR10","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.gtc.2015.07.003","volume":"44","author":"S Lingala","year":"2015","unstructured":"Lingala, S. & Ghany, M. G. Natural history of hepatitis C. Gastroenterol. Clin. North Am. 44, 717\u2013734. https:\/\/doi.org\/10.1016\/j.gtc.2015.07.003 (2015).","journal-title":"Gastroenterol. Clin. North Am."},{"key":"49046_CR11","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1186\/s12913-016-1578-0","volume":"16","author":"EM Ba-Essa","year":"2016","unstructured":"Ba-Essa, E. M., Mobarak, E. I. & Al-Daghri, N. M. Hepatitis C virus infection among patients with diabetes mellitus in Dammam, Saudi Arabia. BMC Health Serv. Res. 16, 313. https:\/\/doi.org\/10.1186\/s12913-016-1578-0 (2016).","journal-title":"BMC Health Serv. Res."},{"key":"49046_CR12","doi-asserted-by":"publisher","first-page":"160","DOI":"10.11604\/pamj.2018.31.160.17176","volume":"31","author":"PK Kombi","year":"2018","unstructured":"Kombi, P. K. et al. Seroprevalence of hepatitis B and C virus infections among diabetic patients in Kisangani (North-eastern Democratic Republic of Congo). Pan Afr. Med. J. 31, 160. https:\/\/doi.org\/10.11604\/pamj.2018.31.160.17176 (2018).","journal-title":"Pan Afr. Med. J."},{"key":"49046_CR13","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1590\/s0100-879x2012007500013","volume":"45","author":"LF Greca","year":"2012","unstructured":"Greca, L. F., Pinto, L. C., Rados, D. R., Canani, L. H. & Gross, J. L. Clinical features of patients with type 2 diabetes mellitus and hepatitis C infection. Braz. J. Med. Biol. Res. 45, 284\u2013290. https:\/\/doi.org\/10.1590\/s0100-879x2012007500013 (2012).","journal-title":"Braz. J. Med. Biol. Res."},{"key":"49046_CR14","doi-asserted-by":"publisher","first-page":"40","DOI":"10.11604\/pamj.2014.17.40.2465","volume":"17","author":"D Mekonnen","year":"2014","unstructured":"Mekonnen, D., Gebre-Selassie, S., Fantaw, S., Hunegnaw, A. & Mihret, A. Prevalence of hepatitis B virus in patients with diabetes mellitus: a comparative cross sectional study at Woldiya General Hospital, Ethiopia. Pan Afr. Med. J. 17, 40. https:\/\/doi.org\/10.11604\/pamj.2014.17.40.2465 (2014).","journal-title":"Pan Afr. Med. J."},{"key":"49046_CR15","doi-asserted-by":"publisher","first-page":"642","DOI":"10.4103\/jfmpc.jfmpc_1158_19","volume":"9","author":"MA Merza","year":"2020","unstructured":"Merza, M. A. Seroprevalence and risk factors of hepatitis B and C viruses among diabetes mellitus patients in Duhok province, Iraqi Kurdistan. J. Family Med. Prim. Care 9, 642\u2013646. https:\/\/doi.org\/10.4103\/jfmpc.jfmpc_1158_19 (2020).","journal-title":"J. Family Med. Prim. Care"},{"key":"49046_CR16","doi-asserted-by":"publisher","first-page":"143","DOI":"10.2147\/jhc.S222609","volume":"6","author":"Y Million","year":"2019","unstructured":"Million, Y. et al. Hepatitis B and hepatitis C viral infections and associated factors among patients with diabetes visiting gondar referral teaching hospital, Northwest Ethiopia: A comparative cross-sectional study. J. Hepatocell. Carcinoma 6, 143\u2013150. https:\/\/doi.org\/10.2147\/jhc.S222609 (2019).","journal-title":"J. Hepatocell. Carcinoma"},{"key":"49046_CR17","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1038\/ajg.2010.173","volume":"105","author":"AK Waljee","year":"2010","unstructured":"Waljee, A. K. & Higgins, P. D. R. Machine learning in medicine: A primer for physicians. Am. J. Gastroenterol. 105, 1224\u20131226. https:\/\/doi.org\/10.1038\/ajg.2010.173 (2010).","journal-title":"Am. J. Gastroenterol."},{"key":"49046_CR18","doi-asserted-by":"publisher","DOI":"10.1007\/s13369-022-07365-5","author":"A Akbas","year":"2022","unstructured":"Akbas, A. & Buyrukoglu, S. Stacking ensemble learning-based wireless sensor network deployment parameter estimation. Arab. J. Sci. Eng. https:\/\/doi.org\/10.1007\/s13369-022-07365-5 (2022).","journal-title":"Arab. J. Sci. Eng."},{"key":"49046_CR19","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1007\/s11517-022-02749-z","volume":"61","author":"A Do\u011fru","year":"2023","unstructured":"Do\u011fru, A., Buyruko\u011flu, S. & Ar\u0131, M. A hybrid super ensemble learning model for the early-stage prediction of diabetes risk. Med. Biol. Eng. Comput. 61, 785\u2013797. https:\/\/doi.org\/10.1007\/s11517-022-02749-z (2023).","journal-title":"Med. Biol. Eng. Comput."},{"key":"49046_CR20","doi-asserted-by":"publisher","first-page":"110","DOI":"10.17694\/bajece.973129","volume":"10","author":"S Buyruko\u011flu","year":"2022","unstructured":"Buyruko\u011flu, S. & Akba\u015f, A. Machine learning based early prediction of type 2 diabetes: A new hybrid feature selection approach using correlation matrix with heatmap and SFS. Balkan J. Electr. Comput. Eng. 10, 110\u2013117. https:\/\/doi.org\/10.17694\/bajece.973129 (2022).","journal-title":"Balkan J. Electr. Comput. Eng."},{"key":"49046_CR21","first-page":"70","volume":"7","author":"G Uzut","year":"2020","unstructured":"Uzut, G. & Buyrukoglu, S. Hyperparameter optimization of data mining algorithms on car evaluation dataset. Euroasia J. Math. Eng. Nat. Med. Sci. 7, 70\u201376 (2020).","journal-title":"Euroasia J. Math. Eng. Nat. Med. Sci."},{"key":"49046_CR22","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s13098-021-00767-9","volume":"13","author":"L Fregoso-Aparicio","year":"2021","unstructured":"Fregoso-Aparicio, L., Noguez, J., Montesinos, L. & Garc\u00eda-Garc\u00eda, J. A. Machine learning and deep learning predictive models for type 2 diabetes: A systematic review. Diabetol. Metab. Syndr. 13, 148. https:\/\/doi.org\/10.1186\/s13098-021-00767-9 (2021).","journal-title":"Diabetol. Metab. Syndr."},{"key":"49046_CR23","doi-asserted-by":"publisher","first-page":"515","DOI":"10.3389\/fgene.2018.00515","volume":"9","author":"Q Zou","year":"2018","unstructured":"Zou, Q. et al. Predicting diabetes mellitus with machine learning techniques. Front. Genet. 9, 515. https:\/\/doi.org\/10.3389\/fgene.2018.00515 (2018).","journal-title":"Front. Genet."},{"key":"49046_CR24","doi-asserted-by":"publisher","DOI":"10.1109\/IJCNN.2003.1223422","author":"L Ozyilmaz","year":"2003","unstructured":"Ozyilmaz, L. & Yildirim, T. Artificial neural networks for diagnosis of hepatitis disease. Surg. Endosc. https:\/\/doi.org\/10.1109\/IJCNN.2003.1223422 (2003).","journal-title":"Surg. Endosc."},{"key":"49046_CR25","doi-asserted-by":"publisher","first-page":"892371","DOI":"10.3389\/fpubh.2022.892371","volume":"10","author":"MO Edeh","year":"2022","unstructured":"Edeh, M. O. et al. Artificial intelligence-based ensemble learning model for prediction of hepatitis C disease. Front. Public Health 10, 892371. https:\/\/doi.org\/10.3389\/fpubh.2022.892371 (2022).","journal-title":"Front. Public Health"},{"key":"49046_CR26","doi-asserted-by":"publisher","first-page":"102087","DOI":"10.1016\/j.datak.2022.102087","volume":"142","author":"M Ya\u011fano\u011flu","year":"2022","unstructured":"Ya\u011fano\u011flu, M. Hepatitis C virus data analysis and prediction using machine learning. Data Knowl. Eng. 142, 102087. https:\/\/doi.org\/10.1016\/j.datak.2022.102087 (2022).","journal-title":"Data Knowl. Eng."},{"key":"49046_CR27","doi-asserted-by":"publisher","DOI":"10.1007\/978-981-16-7610-9_54","volume-title":"A Comparison of Machine Learning Techniques for Categorization of Blood Donors Having Chronic Hepatitis C Infection","author":"S Bhingarkar","year":"2022","unstructured":"Bhingarkar, S. A Comparison of Machine Learning Techniques for Categorization of Blood Donors Having Chronic Hepatitis C Infection (Springer Nature Singapore, 2022). https:\/\/doi.org\/10.1007\/978-981-16-7610-9_54."},{"key":"49046_CR28","doi-asserted-by":"publisher","unstructured":"Syafa\u2019ah, L., Zulfatman, Z., Pakaya, I. & Lestandy, M. Comparison of machine learning classification methods in hepatitis C virus. Jurnal Online Informatika 6, 73\u201378. https:\/\/doi.org\/10.15575\/join.v6i1.719 (2021).","DOI":"10.15575\/join.v6i1.719"},{"key":"49046_CR29","doi-asserted-by":"publisher","first-page":"11127","DOI":"10.3390\/app122111127","volume":"12","author":"G Obaido","year":"2022","unstructured":"Obaido, G. et al. An interpretable machine learning approach for hepatitis B diagnosis. Appl. Sci. 12, 11127. https:\/\/doi.org\/10.3390\/app122111127 (2022).","journal-title":"Appl. Sci."},{"key":"49046_CR30","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.3390\/healthcare11121808","volume":"11","author":"P Mahajan","year":"2023","unstructured":"Mahajan, P., Uddin, S., Hajati, F. & Moni, M. A. Ensemble learning for disease prediction: A review. Healthcare 11, 1808. https:\/\/doi.org\/10.3390\/healthcare11121808 (2023).","journal-title":"Healthcare"},{"key":"49046_CR31","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1186\/s12911-019-0918-5","volume":"19","author":"A Dinh","year":"2019","unstructured":"Dinh, A., Miertschin, S., Young, A. & Mohanty, S. D. A data-driven approach to predicting diabetes and cardiovascular disease with machine learning. BMC Med. Inform. Decis. Mak. 19, 211. https:\/\/doi.org\/10.1186\/s12911-019-0918-5 (2019).","journal-title":"BMC Med. Inform. Decis. Mak."},{"key":"49046_CR32","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/s41598-022-05594-0","volume":"12","author":"D Li","year":"2022","unstructured":"Li, D., Liu, Z., Armaghani, D. J., Xiao, P. & Zhou, J. Novel ensemble intelligence methodologies for rockburst assessment in complex and variable environments. Sci. Rep. 12, 184. https:\/\/doi.org\/10.1038\/s41598-022-05594-0 (2022).","journal-title":"Sci. Rep."},{"key":"49046_CR33","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s13054-019-2351-7","volume":"23","author":"Y Raita","year":"2019","unstructured":"Raita, Y. et al. Emergency department triage prediction of clinical outcomes using machine learning models. Crit. Care 23, 64. https:\/\/doi.org\/10.1186\/s13054-019-2351-7 (2019).","journal-title":"Crit. Care"},{"key":"49046_CR34","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1111\/liv.14820","volume":"41","author":"SB Ahn","year":"2021","unstructured":"Ahn, S. B. et al. Twelve-month post-treatment parameters are superior in predicting hepatocellular carcinoma in patients with chronic hepatitis B. Liver Int. 41, 1652\u20131661. https:\/\/doi.org\/10.1111\/liv.14820 (2021).","journal-title":"Liver Int."},{"key":"49046_CR35","doi-asserted-by":"publisher","DOI":"10.2139\/ssrn.3288893","author":"J Choi","year":"2018","unstructured":"Choi, J., Han, S. W., Jun, D. W. & Ahn, S. B. First year clinical parameters are superior to that of the pre-treatment results for hepatocellular carcinoma prediction in patient with chronic hepatitis B. SSRN https:\/\/doi.org\/10.2139\/ssrn.3288893 (2018).","journal-title":"SSRN"},{"key":"49046_CR36","doi-asserted-by":"publisher","first-page":"21716","DOI":"10.1038\/s41598-020-78716-1","volume":"10","author":"Y Wu","year":"2020","unstructured":"Wu, Y. et al. A prediction nomogram for the 3-year risk of incident diabetes among Chinese adults. Sci. Rep. 10, 21716. https:\/\/doi.org\/10.1038\/s41598-020-78716-1 (2020).","journal-title":"Sci. Rep."},{"key":"49046_CR37","doi-asserted-by":"publisher","first-page":"2205510","DOI":"10.1080\/13685538.2023.2205510","volume":"26","author":"Q Ou","year":"2023","unstructured":"Ou, Q. et al. LASSO-based machine learning algorithm to predict the incidence of diabetes in different stages. Aging Male 26, 2205510. https:\/\/doi.org\/10.1080\/13685538.2023.2205510 (2023).","journal-title":"Aging Male"},{"key":"49046_CR38","doi-asserted-by":"publisher","first-page":"4962","DOI":"10.3390\/ijerph20064962","volume":"20","author":"J-Y Han","year":"2023","unstructured":"Han, J.-Y., Kwon, J.-H., Kim, S.-H. & Lee, H. Hepatitis risk in diabetes compared to non-diabetes and relevant factors: A cross-sectional study with national health and nutrition examination survey (NHANES). Int. J. Environ. Res. Public Health 20, 4962. https:\/\/doi.org\/10.3390\/ijerph20064962 (2023).","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"49046_CR39","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.jhep.2012.11.004","volume":"58","author":"SA McDonald","year":"2013","unstructured":"McDonald, S. A. et al. Decrease in health-related quality of life associated with awareness of hepatitis C virus infection among people who inject drugs in Scotland. J. Hepatol. 58, 460\u2013466. https:\/\/doi.org\/10.1016\/j.jhep.2012.11.004 (2013).","journal-title":"J. Hepatol."},{"key":"49046_CR40","doi-asserted-by":"publisher","first-page":"240","DOI":"10.2337\/dc09-1348","volume":"33","author":"M Peyrot","year":"2010","unstructured":"Peyrot, M., Rubin, R. R., Kruger, D. F. & Travis, L. B. Correlates of insulin injection omission. Diabetes Care 33, 240\u2013245. https:\/\/doi.org\/10.2337\/dc09-1348 (2010).","journal-title":"Diabetes Care"},{"key":"49046_CR41","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1177\/193229681000400501","volume":"4","author":"DC Klonoff","year":"2010","unstructured":"Klonoff, D. C. & Perz, J. F. Assisted monitoring of blood glucose: special safety needs for a new paradigm in testing glucose. J. Diabetes Sci. Technol. 4, 1027\u20131031. https:\/\/doi.org\/10.1177\/193229681000400501 (2010).","journal-title":"J. Diabetes Sci. Technol."},{"key":"49046_CR42","doi-asserted-by":"publisher","first-page":"655","DOI":"10.2105\/ajph.86.5.655","volume":"86","author":"RS Garfein","year":"1996","unstructured":"Garfein, R. S., Vlahov, D., Galai, N., Doherty, M. C. & Nelson, K. E. Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses. Am. J. Public Health 86, 655\u2013661. https:\/\/doi.org\/10.2105\/ajph.86.5.655 (1996).","journal-title":"Am. J. Public Health"},{"key":"49046_CR43","doi-asserted-by":"publisher","first-page":"46","DOI":"10.2105\/ajph.91.1.46","volume":"91","author":"J Lorvick","year":"2001","unstructured":"Lorvick, J., Kral, A. H., Seal, K., Gee, L. & Edlin, B. R. Prevalence and duration of hepatitis C among injection drug users in San Francisco, Calif. Am. J. Public Health 91, 46\u201347. https:\/\/doi.org\/10.2105\/ajph.91.1.46 (2001).","journal-title":"Am. J. Public Health"},{"key":"49046_CR44","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1097\/00005792-199507000-00005","volume":"74","author":"DL Thomas","year":"1995","unstructured":"Thomas, D. L. et al. Correlates of hepatitis C virus infections among injection drug users. Medicine 74, 212\u2013220. https:\/\/doi.org\/10.1097\/00005792-199507000-00005 (1995).","journal-title":"Medicine"},{"key":"49046_CR45","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1002\/hep.21765","volume":"46","author":"FC Tseng","year":"2007","unstructured":"Tseng, F. C. et al. Seroprevalence of hepatitis C virus and hepatitis B virus among San Francisco injection drug users, 1998 to 2000. Hepatology 46, 666\u2013671. https:\/\/doi.org\/10.1002\/hep.21765 (2007).","journal-title":"Hepatology"},{"key":"49046_CR46","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1093\/oxfordjournals.aje.a009792","volume":"149","author":"H Hagan","year":"1999","unstructured":"Hagan, H. et al. Syringe exchange and risk of infection with hepatitis B and C viruses. Am. J. Epidemiol. 149, 203\u2013213. https:\/\/doi.org\/10.1093\/oxfordjournals.aje.a009792 (1999).","journal-title":"Am. J. Epidemiol."},{"key":"49046_CR47","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1016\/s1473-3099(16)30325-5","volume":"16","author":"L Degenhardt","year":"2016","unstructured":"Degenhardt, L. et al. Estimating the burden of disease attributable to injecting drug use as a risk factor for HIV, hepatitis C, and hepatitis B: Findings from the Global Burden of Disease Study 2013. Lancet Infect. Dis. 16, 1385\u20131398. https:\/\/doi.org\/10.1016\/s1473-3099(16)30325-5 (2016).","journal-title":"Lancet Infect. Dis."},{"key":"49046_CR48","doi-asserted-by":"publisher","first-page":"e0177341","DOI":"10.1371\/journal.pone.0177341","volume":"12","author":"B Eckhardt","year":"2017","unstructured":"Eckhardt, B. et al. Risk factors for hepatitis C seropositivity among young people who inject drugs in New York City: Implications for prevention. PLoS One 12, e0177341. https:\/\/doi.org\/10.1371\/journal.pone.0177341 (2017).","journal-title":"PLoS One"},{"key":"49046_CR49","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1111\/j.1365-2893.2012.01616.x","volume":"19","author":"SF Schillie","year":"2012","unstructured":"Schillie, S. F., Xing, J., Murphy, T. V. & Hu, D. J. Prevalence of hepatitis B virus infection among persons with diagnosed diabetes mellitus in the United States, 1999\u20132010. J. Viral Hepat. 19, 674\u2013676. https:\/\/doi.org\/10.1111\/j.1365-2893.2012.01616.x (2012).","journal-title":"J. Viral Hepat."},{"key":"49046_CR50","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.1038\/srep02981","volume":"3","author":"X Guo","year":"2013","unstructured":"Guo, X., Jin, M., Yang, M., Liu, K. & Li, J.-W. Type 2 diabetes mellitus and the risk of hepatitis C virus infection: A systematic review. Sci. Rep. 3, 2981. https:\/\/doi.org\/10.1038\/srep02981 (2013).","journal-title":"Sci. Rep."},{"key":"49046_CR51","doi-asserted-by":"publisher","first-page":"108637","DOI":"10.1016\/j.diabres.2020.108637","volume":"172","author":"T Turk Wensveen","year":"2021","unstructured":"Turk Wensveen, T., Ga\u0161parini, D., Raheli\u0107, D. & Wensveen, F. M. Type 2 diabetes and viral infection; cause and effect of disease. Diabetes Res. Clin. Pract. 172, 108637. https:\/\/doi.org\/10.1016\/j.diabres.2020.108637 (2021).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"49046_CR52","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1186\/s12889-019-6828-8","volume":"19","author":"LCDC Guimar\u00e3es","year":"2019","unstructured":"Guimar\u00e3es, L. C. D. C. et al. Epidemiology of hepatitis B virus infection in people living in poverty in the central-west region of Brazil. BMC Public Health 19, 443. https:\/\/doi.org\/10.1186\/s12889-019-6828-8 (2019).","journal-title":"BMC Public Health"},{"key":"49046_CR53","doi-asserted-by":"publisher","first-page":"143","DOI":"10.35536\/lje.2011.v16.i1.a6","volume":"16","author":"PZ Janjua","year":"2011","unstructured":"Janjua, P. Z. & Kamal, U. A. The role of education and income in poverty alleviation: A cross-country analysis. Lahore J. Econ. 16, 143\u2013172 (2011).","journal-title":"Lahore J. Econ."},{"key":"49046_CR54","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1002\/hep.29800","volume":"67","author":"NA Terrault","year":"2018","unstructured":"Terrault, N. A. et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology 67, 1560\u20131599. https:\/\/doi.org\/10.1002\/hep.29800 (2018).","journal-title":"Hepatology"},{"key":"49046_CR55","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1002\/hep.31060","volume":"71","author":"MG Ghany","year":"2020","unstructured":"Ghany, M. G. & Morgan, T. R. Hepatitis C guidance 2019 update: American association for the study of liver diseases-infectious diseases society of America recommendations for testing, managing, and treating hepatitis C virus infection. Hepatology 71, 686\u2013721. https:\/\/doi.org\/10.1002\/hep.31060 (2020).","journal-title":"Hepatology"},{"key":"49046_CR56","doi-asserted-by":"publisher","first-page":"e27","DOI":"10.2105\/ajph.2015.302741","volume":"105","author":"SK Greene","year":"2015","unstructured":"Greene, S. K., Levin-Rector, A., Hadler, J. L. & Fine, A. D. Disparities in reportable communicable disease incidence by census tract-level poverty, New York city, 2006\u20132013. Am. J. Public Health 105, e27-34. https:\/\/doi.org\/10.2105\/ajph.2015.302741 (2015).","journal-title":"Am. J. Public Health"},{"key":"49046_CR57","doi-asserted-by":"publisher","first-page":"e20190123","DOI":"10.1590\/0037-8682-0123-2019","volume":"52","author":"CFO Scarponi","year":"2019","unstructured":"Scarponi, C. F. O., Zolnikov, T. R. & Mol, M. P. G. Are waste pickers at risk for hepatitis B and C infections because of poverty or environmental exposures?. Rev. Soc. Bras. Med. Trop. 52, e20190123. https:\/\/doi.org\/10.1590\/0037-8682-0123-2019 (2019).","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"49046_CR58","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1111\/jvh.13380","volume":"27","author":"T Barr\u00e9","year":"2020","unstructured":"Barr\u00e9, T. et al. Cannabis use is associated with a lower risk of diabetes in chronic hepatitis C-infected patients (ANRS CO22 Hepather cohort). J. Viral Hepat. 27, 1473\u20131483. https:\/\/doi.org\/10.1111\/jvh.13380 (2020).","journal-title":"J. Viral Hepat."},{"key":"49046_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2021.107916","volume":"35","author":"L Shi","year":"2021","unstructured":"Shi, L., Fonseca, V. & Childs, B. Economic burden of diabetes-related hypoglycemia on patients, payors, and employers. J. Diabetes Complicat. 35, 107916. https:\/\/doi.org\/10.1016\/j.jdiacomp.2021.107916 (2021).","journal-title":"J. Diabetes Complicat."},{"key":"49046_CR60","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1086\/653622","volume":"202","author":"A Wasley","year":"2010","unstructured":"Wasley, A. et al. The prevalence of hepatitis B virus infection in the United States in the era of vaccination. J. Infect. Dis. 202, 192\u2013201. https:\/\/doi.org\/10.1086\/653622 (2010).","journal-title":"J. Infect. Dis."},{"key":"49046_CR61","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1002\/hep.28109","volume":"63","author":"H Roberts","year":"2016","unstructured":"Roberts, H. et al. Prevalence of chronic hepatitis B virus (HBV) infection in U.S. households: National Health and Nutrition Examination Survey (NHANES), 1988\u20132012. Hepatology 63, 388\u2013397. https:\/\/doi.org\/10.1002\/hep.28109 (2016).","journal-title":"Hepatology"},{"key":"49046_CR62","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1093\/infdis\/jiz479","volume":"221","author":"B Zou","year":"2020","unstructured":"Zou, B. et al. Prevalence of viremic hepatitis C Virus infection by age, race\/ethnicity, and birthplace and disease awareness among viremic persons in the United States, 1999\u20132016. J. Infect. Dis. 221, 408\u2013418. https:\/\/doi.org\/10.1093\/infdis\/jiz479 (2020).","journal-title":"J. Infect. Dis."},{"key":"49046_CR63","doi-asserted-by":"publisher","first-page":"11924","DOI":"10.3748\/wjg.v21.i42.11924","volume":"21","author":"MS Chen Jr","year":"2015","unstructured":"Chen, M. S. Jr. & Dang, J. Hepatitis B among Asian Americans: Prevalence, progress, and prospects for control. World J. Gastroenterol. 21, 11924\u201311930. https:\/\/doi.org\/10.3748\/wjg.v21.i42.11924 (2015).","journal-title":"World J. Gastroenterol."},{"key":"49046_CR64","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/s41467-019-14108-y","volume":"11","author":"R Vinuesa","year":"2020","unstructured":"Vinuesa, R. et al. The role of artificial intelligence in achieving the Sustainable Development Goals. Nat. Commun. 11, 233. https:\/\/doi.org\/10.1038\/s41467-019-14108-y (2020).","journal-title":"Nat. Commun."},{"key":"49046_CR65","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson, M. E., Pompei, P., Ales, K. L. & MacKenzie, C. R. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J. Chronic Dis. 40, 373\u2013383. https:\/\/doi.org\/10.1016\/0021-9681(87)90171-8 (1987).","journal-title":"J. Chronic Dis."},{"key":"49046_CR66","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1001\/jama.295.20.2385","volume":"295","author":"RA Miech","year":"2006","unstructured":"Miech, R. A. et al. Trends in the association of poverty with overweight among US adolescents, 1971\u20132004. Jama 295, 2385\u20132393. https:\/\/doi.org\/10.1001\/jama.295.20.2385 (2006).","journal-title":"Jama"},{"key":"49046_CR67","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s41118-019-0055-0","volume":"75","author":"M Luy","year":"2019","unstructured":"Luy, M. et al. The impact of increasing education levels on rising life expectancy: A decomposition analysis for Italy, Denmark, and the USA. Genus 75, 11. https:\/\/doi.org\/10.1186\/s41118-019-0055-0 (2019).","journal-title":"Genus"},{"key":"49046_CR68","unstructured":"National Center for Health Statistics. National Health and Nutrition Examination Survey. Analytic guidelines; 2011\u20132014 and 2015\u20132016. https:\/\/wwwn.cdc.gov\/nchs\/nhanes\/analyticguidelines.aspx (2022)"},{"key":"49046_CR69","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare11192699","author":"S Ozgur","year":"2023","unstructured":"Ozgur, S., Altinok, Y. A., Bozkurt, D., Sara\u00e7, Z. F. & Ak\u00e7i\u00e7ek, S. F. performance evaluation of machine learning algorithms for sarcopenia diagnosis in older adults. Healthcare (Basel) https:\/\/doi.org\/10.3390\/healthcare11192699 (2023).","journal-title":"Healthcare (Basel)"},{"key":"49046_CR70","doi-asserted-by":"publisher","first-page":"765693","DOI":"10.3389\/fcvm.2021.765693","volume":"8","author":"S Sanchez-Martinez","year":"2021","unstructured":"Sanchez-Martinez, S. et al. Machine learning for clinical decision-making: Challenges and opportunities in cardiovascular imaging. Front. Cardiovasc. Med. 8, 765693. https:\/\/doi.org\/10.3389\/fcvm.2021.765693 (2021).","journal-title":"Front. Cardiovasc. Med."},{"key":"49046_CR71","doi-asserted-by":"publisher","first-page":"103825","DOI":"10.1016\/j.medengphy.2022.103825","volume":"105","author":"J Azmi","year":"2022","unstructured":"Azmi, J. et al. A systematic review on machine learning approaches for cardiovascular disease prediction using medical big data. Med. Eng. Phys. 105, 103825. https:\/\/doi.org\/10.1016\/j.medengphy.2022.103825 (2022).","journal-title":"Med. Eng. Phys."},{"key":"49046_CR72","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s12916-014-0145-y","volume":"12","author":"AA Mokdad","year":"2014","unstructured":"Mokdad, A. A. et al. Liver cirrhosis mortality in 187 countries between 1980 and 2010: A systematic analysis. BMC Med. 12, 145. https:\/\/doi.org\/10.1186\/s12916-014-0145-y (2014).","journal-title":"BMC Med."},{"key":"49046_CR73","doi-asserted-by":"publisher","first-page":"81321","DOI":"10.18632\/oncotarget.18466","volume":"8","author":"PH Hsieh","year":"2017","unstructured":"Hsieh, P. H. et al. Association of type 2 diabetes with liver cirrhosis: a nationwide cohort study. Oncotarget 8, 81321\u201381328. https:\/\/doi.org\/10.18632\/oncotarget.18466 (2017).","journal-title":"Oncotarget"},{"key":"49046_CR74","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.jiph.2018.08.003","volume":"12","author":"KJ Moore","year":"2019","unstructured":"Moore, K. J., Gauri, A. & Koru-Sengul, T. Prevalence and sociodemographic disparities of Hepatitis C in Baby Boomers and the US adult population. J. Infect. Public Health 12, 32\u201336. https:\/\/doi.org\/10.1016\/j.jiph.2018.08.003 (2019).","journal-title":"J. Infect. Public Health"},{"key":"49046_CR75","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1111\/jgh.13788","volume":"32","author":"T Tada","year":"2017","unstructured":"Tada, T. et al. Improvement of liver stiffness in patients with hepatitis C virus infection who received direct-acting antiviral therapy and achieved sustained virological response. J. Gastroenterol. Hepatol. 32, 1982\u20131988. https:\/\/doi.org\/10.1111\/jgh.13788 (2017).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"49046_CR76","doi-asserted-by":"publisher","first-page":"641806","DOI":"10.3389\/fpsyg.2021.641806","volume":"12","author":"Z Ren","year":"2021","unstructured":"Ren, Z. et al. Psychological impact of COVID-19 on college students after school reopening: A cross-sectional study based on machine learning. Front. Psychol. 12, 641806. https:\/\/doi.org\/10.3389\/fpsyg.2021.641806 (2021).","journal-title":"Front. Psychol."},{"key":"49046_CR77","doi-asserted-by":"publisher","first-page":"20","DOI":"10.4258\/hir.2020.26.1.20","volume":"26","author":"H Symum","year":"2020","unstructured":"Symum, H. & Zayas-Castro, J. L. Prediction of chronic disease-related inpatient prolonged length of stay using machine learning algorithms. Healthc. Inform. Res. 26, 20\u201333. https:\/\/doi.org\/10.4258\/hir.2020.26.1.20 (2020).","journal-title":"Healthc. Inform. Res."},{"key":"49046_CR78","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12874-019-0681-4","volume":"19","author":"JAM Sidey-Gibbons","year":"2019","unstructured":"Sidey-Gibbons, J. A. M. & Sidey-Gibbons, C. J. Machine learning in medicine: A practical introduction. BMC Med. Res. Methodol. 19, 64. https:\/\/doi.org\/10.1186\/s12874-019-0681-4 (2019).","journal-title":"BMC Med. Res. Methodol."},{"key":"49046_CR79","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-540-31865-1_25","volume-title":"A Probabilistic Interpretation of Precision, Recall and F-Score, with Implication for Evaluation","author":"C Goutte","year":"2005","unstructured":"Goutte, C. & Gaussier, E. A Probabilistic Interpretation of Precision, Recall and F-Score, with Implication for Evaluation (Springer, 2005)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-49046-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-49046-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-49046-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T13:42:54Z","timestamp":1701870174000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-49046-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,6]]},"references-count":79,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["49046"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-49046-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,6]]},"assertion":[{"value":"3 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21518"}}